Identification of therapeutic targets in uterine sarcoma KU Leuven
Uterine sarcomas account for only 3-4% of all uterine corpus malignancies, nevertheless they entail a high mortality rate due to their clinical aggressiveness and limited response to current treatments. All uterine sarcoma patients are first treated by complete surgical resection, whenever possible (hysterectomy, often associated with bilateral salpingo-oophorectomy). However, recurrence rates are high in most subtypes even after complete ...